We examined the rate of glucose utilization and the rate of valine incorporation into proteins using 2-Psp]fluoro-2-deoxyglucose and L-[l-14C]-valine in a rat brain tumor model by quantitative double-tracer autora diography. We found that in the implanted tumor the rate of valine incorporation into proteins was about 22 times and the rate of glucose utilization was about 1. 5 times that in the contralateral cortex. (In the ipsilateral cortex, the tumor had a profound effect on glucose utilization but no effect on the rate of valine incorporation into proteins.) Our findings suggest that it is more useful to measure protein synthesis than glucose utilization to assess the effectiveness of antitumor agents and their toxicity to
The functional biochemistry of the brain has been measured in vivo in a variety of animals since the development of auto radiographic methods for as sessing the physiological variables in normal (Sokoloff et aI., 1977; Dwyer et aI., 1982; Furlow et aI., 1983; Mies et aI., 1986) and pathological (Blas berg et aI., 1980 (Blas berg et aI., , 1983 Hossmann et aI., 1982; Kato et aI., 1985a Kato et aI., , 1985b conditions.
Methods have been developed to measure re-normal brain tissue. We compared two methods to esti mate the rate of valine incorporation: "kinetic" (quanti tation done using an operational equation and the average brain rate coefficients) and "washed slices" (unbound labeled valine removed by washing brain slices in 10% thrichloroacetic acid). The results were the same using either method. It would seem that the kinetic method can thus be used for quantitative measurement of protein syn thesis in brain tumors and normal brain tissue using [llC]-valine with positron emission tomography. Key Words: Double-tracer autoradiography-Brain protein synthesis-Tumor protein synthesis-Glucose utilization-Glucose-protein synthesis relation.
gional cerebral blood flow (rCBF) (e.g., Sakurada et aI., 1978; Sako et aI., 1984; Mies et aI., 1981) , glu cose utilization (rCGlu) (e.g., Sokoloff et aI. 1977; Sako et aI., 1984; Reivich et aI. 1979) , and protein synthesis (e.g., Dwyer et aI., 1982; Kennedy et aI., 1981; Hossmann et aI., 1983; Smith et aI., 1984; Kiessling et aI., 1982) . Methods have also been de veloped to measure two (e.g., Kato et aI., 1985b; Sako et aI., 1984; Lear et aI., 1981) , three (e.g., Hossmann et aI., 1983; Mies et aI., 1983; Nakai et aI., 1988) , and more (Hossmann et aI., 1985) patho physiological variables in the brain of the same an imal. Multitracer autoradiography is specially im portant because it removes some of the animal to-animal variability. It has been used to investigate various animal tumor models (e.g., Blasberg et aI., 1980; Kato et aI., 1985b; Hossmann et aI. , 1983; Groothuis et aI., 1983) , and rCBF, rCGlu, and re gional cerebral pH (rCpH). A very distinct and size dependent relationship has been shown to exist be-tween different parameters in the tumor itself and in the surrounding brain (Kato et aI., 1985b) . Since tumor cells proliferate rapidly (Warburg, 1930) and require large amounts of protein to build the fast-growing tissue, an abnormally high rate of protein synthesis should be expected in tumors. Two different biological models for measurement of the rate of protein synthesis (more accurately the rate of amino acid incorporation into proteins) have been reported in the literature (Smith et aI., 1984; Bustany et aI., 1981) . These models are based on two different essential amino acids, methionine (S methyl labeled) and I-C-Iabeled leucine. Both mod els apply tracer kinetic principles to describe the kinetic behavior of amino acid after labeled amino acid is given to the biological system. Since exper iments take a "short" time, a correction should be made for the presence of the free label in the plasma and precursor pool, and the lag time for the equili bration between supply pool (plasma) and extracel lular pool. These corrections can be made mathe matically if the rate constant for the transfer of amino acid from plasma to brain through the blood brain barrier (Kf) and back (ki), the rate constant for decarboxylation (metabolic degradation) of 1-C-Iabeled amino acid (kj), and the incorporation of labeled amino acid into protein (k4) are known. (The rate constant kt is actually the constant for the rate-limiting step in the protein synthesis metabolic pathway.) An alternative correction is to remove free amino acid from the brain tissue before deter mining the concentration of the protein-incorpo rated amino acid (Blasberg et aI., 1980; Dienel et aI., 1980; Yoshimine et aI., 1987; Kirikae et aI., 1988) . The latter is allowed only if there is a "sufficiently" long time between injection and kill ing, permitting equilibration between plasma and "extracellular" compartments. Blasberg et al. (1981) applied the washing method of quantitative autoradiography to an experimental brain tumor model. Yoshimine et al. (1987) recently assessed valine incorporation into gerbil brain after focal ischemia. [They removed nonbound amino acid by washing in trichloracetic acid (TCA).] In this paper, we describe the use of the tracer L-[l_14C]-valine e4C-valine) to measure the rate of valine incorporation into proteins in the rat brain tumor model. We also assess the influence of the tumor mass on the valine incorporation rate and glucose utilization in the ipsilateral cortex. We com pare two methods for measuring protein synthesis using L-[l_14C]-valine: the kinetic method (using the rate constants in the estimation of valine incorpo ration rate) and the washing method (where free valine was removed).
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MATERIALS AND METHODS

Tracers
L-[1-14C]-valine (specific activity of 55.5 mCilmmoi) was obtained from Amersham Corp. (Arlington Heights, IL, U.S.A.). 18P-labeled 2-fluoro-2-deoxY-D-glucose e8p-2-PDG) (specific activity of about 350 mCilmmol at the time of administration) was prepared in our Medical Cy clotron Unit by a method described elsewhere (Diksic and Jolly, 1983) .
Animal preparation
AA ascites tumor (Aptekman and Bogden, 1955 ) ob tained from the Mason Research Institute (Worcester, MA, U.S.A.) was transformed into solid form in our lab oratory by a method described earlier (Arita et aI., 1983) . Adult female Wi star rats, with a body weight 170 to 200 g, were anesthetized by an intraperitoneal injection of 50 mg/kg pentobarbital (N embutal). A tumor fragment ob tained by mincing with scissors (0.5 mm in diameter) was then injected into the right parietal lobe through a burr hole drilled 2 mm to the right of the sagittal suture and close to the coronal suture. A 5 /Ll microdispensor syringe (Drummond, Broomall, PA, U.S.A.) was sterilized and used for inoculation. The hole was sealed with a fragment of galea aponeurotica from the animal itself. Experiments were performed 5 to 7 days after the tumor implantation.
Seven tumor-inoculated rats were used in this study. They were fasted except for water at least 12 h before the experiment. On the day of the experiment, animals were anesthetized with 1.5 to 2.0% halothane for cannulation of the femoral artery and vein. The lower half of their body was immobilized with a loose-fitting plaster cast taped to a lead block and they were allowed to waken from anesthesia for 2 to 3 h before being injected with tracers. Body temperature was maintained around 36°C with the aid of a lamp. Arterial blood pressure, Pa02, PaC02, pH, and arterial plasma glucose concentration were monitored during the recovery period, just before, and during the experiment. The physiological measure ments are shown in Table 1 .
Double-tracer autoradiography
The methodology applied in this double-tracer autora diography is described in detail elsewhere (Sako et aI., 1984) . At time zero, 4 to 5 mCi of 18p_2_PDG dissolved in 1 ml of buffered saline was injected intravenously during 1 min as an extended bolus. In four rats, 25 /LCi of [1-14C]-valine was injected intravenously over 60 s, 15 min after the beginning of 18p_2_PDG injection. These animals were killed 45 min after 18p_2_PDG injection. In three rats, 14C-valine (25 /LCi) was injected 45 minutes before injection of 18p_2_PDG. The rats were killed 90 min after the 14C-valine injection and 45 min after the 18F-2-FDG injection. Arterial blood samples were withdrawn in order to measure plasma 18F-2-FDG, 14C-valine (after precipitat ing proteins with TCA), glucose concentration, and total free valine concentration (deproteinized plasma). The samples were usually taken at 0. 5, 0.75, I, 1.5, 2.5, 3.5, 5.5, 7.5, 12.5, 15.5, 19, 25, 35, 40 , and 45 min after injec tion of the tracer in 45 min experiments. In 90 min exper iments, additional samples were taken at 10 min intervals for up to 90 min. Plasma valine concentration was usually measured in three plasma samples taken just before in jection of 14C-valine, 5 min after the end of injection, and at the time of kill. The average of three determinations was used in the calculation. The blood samples were im mediately centrifuged at 12,000 g and the plasma samples deproteinized with 10% TCA. The plasma 14C-valine ra dioactivity was measured by liquid scintillation and the valine concentration in the plasma was measured by HPLC using a published method (Bidlingmeyer et aI., 1987) described in detail in our previous paper (Kirikae et aI., 1987) .
The brain was sectioned into slices 30 /Lm thick, with neighboring slices being mounted on two different micro scopic glasses. One set was used for washing with TCA (details described below); the other was used without any further manipUlation. The 18F standards were prepared in each experiment. Between 0.01 and 0. 1 mCilg brain of 18F compound (most often 18F-2-FDG) was mixed with homog enized calf brain. The mixture was homogenously mixed by passage through a three-way stopcock connected be tween two syringes (Sako et aI., 1984) . Standards were frozen by immersing them in liquid freon-12. The mid portion of the standards was sliced into 30 /Lm thick slices in a cryostat at -2SOC and exposed to Kodak SB-5 films in an x-ray cassette, along with the brain tissue slices. The remainder of a standard was assayed for 18F radio activity in aNal (Tl) well counter to obtain absolute con centration of standards (nCilg-brain). The polymer 14C standards, obtained from Amersham Corp. and calibrated to 20 /Lm tissue-equivalent sections of the rat brain gray matter, were also present during the first exposure, which lasted 2 h. These images represented the distribution of 18F_FDG used to estimate regional glucose utilization. The contamination from 14C-radioactivity in the first ex posure for measurement of 18F-radioactivity was found to be less than 5% in the tumor area, where the maximum contamination was found. This was confirmed in two dif ferent ways: first, from the images of 14C standards pro duced during the first exposure and, second, by exposing films to tissue slices for 2, 3, and 6 h after 18F decay. Before the second exposure, one set of slices was washed to remove free valine from the brain slices, as described by Dwyer et a!. (1982) . Slices were washed three times with ice-cold (about 4°C) 10% TCA containing 0. 1 % L valine and rinsed three times with ice-cold (about 4°C) distilled water.
Three days later, a second 3 week exposure to obtain brain tissue radioactivity corresponding to 14C-valine be gun. There were two different sets of brain slices, one washed and the other unwashed. The images from un washed slices reflected total tissue radioactivity related to 14C-valine (free 14C-valine and protein-bound 14C-valine); the images from washed slices reflected only protein bound 14C-valine. Usually, the images of both sets (washed and unwashed), along with standards, were exposed simultaneously to reduce the effect of background darkening of the film on the quantitative determination of the tissue tracer concentration. Commercial standards were recalibrated to a 30 /Lm brain tissue equivalent by coexposing them with a set of 14C-brain tissue standards prepared in the same manner as described above for 18F standards, with the difference that 14C radioactivity was determined by liquid scintillation. Since there was a large difference in the isotope concentration in the tumor and brain, a third I-week exposure was necessary. During all exposures, cassettes were kept in a refrigerator at around 5°C. To ascertain the tumor size and morphology, the brain sections neighboring those used for autoradiogra phy, or the same sections, were stained with hematoxylin and eosin (HE) for histopathological examination after exposure.
Measurement of local cerebral glucose utilization rate
Local glucose utilization rates (Rg1u) of the brain and the tumor tissue were estimated using the three compartment model described by Sokoloff et a!. (1977) . The normal brain glucose utilization was calculated using normal brain rate constants for 2-deoxy-o-glucose (Sokoloff et a!., 1977) and the rate constants for 2-fluoro-2-deoxy-o-glucose (Redies et a!., 1987) . As shown earlier by Kato et a!. (1985a) , there is no difference in glucose utilization using either set of rate constants. The lumped constant used for normal brain (LC = 0.89) was that reported by Crane et a!. (1983) . The rate and lumped constants used to quantify tumor glucose utilization were taken from Kato et a!. (1985a) . A I-week exposure was used. Even when the tumor had a large concentration of tracers, the optical density was linearly related to radio activity for one week of exposure. The glucose utilization equation used in the calculation is (Sokoloff et a!., 1977) CE:
where C p is the plasma glucose concentration, and C; (n and C; are tissue and plasma radioactivity concentration, respectively. C� (n is the concentration of label in the precursor pool mathematically estimated, and Kj, ki, and kj are the first-order transfer coefficients for the transfer of label among different biological compartments (Fig. l) .
Measurement of regional incorporation of valine into brain proteins
The regional incorporation of valine into proteins [also called the regional rate of protein synthesis (rRPS)] was calculated on the basis of a three-compartment biological model described by Smith et a!. (1984) . The rate constants measured in normal brain (Kirikae et a!., 1988) were used in the quantitation of tumor and brain rRPS. The model can be briefly described by three "distinct" pools of 14C radioactivity originating from L-[l_14C]-valine (Fig. 1) 
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mathematical entity constructed as an approximation to physical reality" (N orwich, 1977) .] The plasma 14C_ valine is transported through the blood-brain barrier (BBB) by the amino acid transport system with the rate coefficient Kf (plasma to brain), kJ. (brain to plasma), and k! (incorporated into proteins). Metabolic catabolism of L-valine (kj) also occurs, but in this process the label is lost as [14C]-COZ' which leaves the brain very quickly. It therefore does not contribute substantially to the total brain radioactivity measured by either autoradiography or liquid scintillation.
As Smith et al. (1984) , Phelps et al. (1984) , and Kirikae et al. (1988) pointed out, the rRPS can be quantified by this approach only if (a) the brain protein synthesis is in a steady state that is not changed during experiments; (b) there is no label released from protein into the tissue-free valine pool during the experiment; (c) the absolute amount of valine introduced with the injection of labeled valine does not influence in any way the brain tissue steady state or the plasma valine concentration. We would add that the method has two further requirements: (d) there is a rate-limiting step in the incorporation of valine into brain proteins and that step is not the blood brain barrier transport; (e) all rates can be described by the first-order kinetics. When all five conditions are ful filled, the plasma tracer concentration and its time profile can be used as an input function to the biological model. We have called the method described above the kinetic method and will compare it to the washed slices method in which free valine was removed by washing from the tissue slices. In the case of TCA-washed slices, the rate of the valine incorporation into proteins [Rpr(T) in nmol/g/min] can be calculated as (Gaitonde, 1965) 
where C;; is the plasma valine concentration in nmol/ml, q is the tissue radioactivity (nCilg brain) after TCA washing e4C-valine incorporated into proteins), and C; is the concentration of tracer in the plasma (nCi/mI). For the kinetic model the rate of incorporation [R�r (1)] was cal culated using the following equation (Smith et aI., 1984; Kirikae et aI., 1988 
Other symbols are the same as mentioned above. The regions of interest analyzed were tumor tissue (avoiding necrotic lesion by reference to the HE staining of the corresponding slice) and pyramidal layers of both ipsilateral and contralateral parietal cortex.
RESULTS
Approximately 7 days after tumor inoculation, rats became drowsy and exhibited shaggy fur. Some rats had bilateral exophthalmos 8 days after inocu lation. By the tenth day after the implantation, all rats died of the tumor. Macroscopically, maximal diameters of tumors ranged from 2 to 6 mm. The tumor centers were usually within the right hippo campal region and expanded towards both cortical and thalamic regions (Fig. 2) . Pathohistologically, tumor tissue consisted of diffuse, tight, hematoxy lin-rich cells. The tumor margin was very clear and central necrosis was often observed. Table 1 shows the physiological parameters of animals used in this study. These variables did not differ significantly between tumor and control rats. Representative au toradiograms are shown in Fig. 2 . Table 2 shows the rates of glucose utilization and protein synthesis estimated in the ipsilateral and contralateral cortices and in implanted brain tumor. Table 3 shows the rate of valine incorporation into proteins in several other structures, estimated by both the kinetic and washed slices methods. The rate of protein synthesis in the tumor is 23 times that in the ipsilateral normal cortex and 22 times that in the contralateral cortex. The protein synthe sis rate did not differ significantly between the ip- silateral parietal and contralateral parietal cortices. However, the rate of glucose utilization in the tu mor is only 1.5 times that of the contralateral pari etal cortex and 2. 2 times that of the ipsilateral pa rietal cortex. The rate of glucose utilization in the ipsilateral parietal cortex is 45% lower than that in the contralateral parietal cortex. Table 3 shows the rate of valine incorporation into protein estimated in the washed and unwashed brain slices. There is excellent agreement between the rates of valine in corporation estimated by both methods ( Table 3 ), suggesting that the rate constants for valine are a reasonable representation of the actual kinetic pro cess and/or the model is insensitive to the rate con stants to kill times used. Since the tumor has a very high rate of protein synthesis, there is no influence of the rate constants used on the calculated results (Sokoloff et aI., 1977; Kato et aI., 1985a,b) .
Both glucose utilization and protein synthesis in the brain tumor tissue are higher than in the normal contralateral parietal cortex. Comparison between measurements in normal rats (Table 2, in Kirikae et aI., 1988) for protein synthesis and glucose utiliza tion (Sokoloff et aI., 1977; Kato et aI., 1985b) and results reported here for tumor-bearing rats (Table  2) suggest that the contralateral brain has glucose utilization and protein synthesis rates similar to those in the normal adult rat brain. However, the glucose utilization in the ispilateral cortex is about 30% lower than in the contralateral cortex (Table 2) . We observed no significant change in protein syn thesis (Table 2) between two sides.
Comparison of washed and unwashed slices (ac tual data not shown) revealed that 30% of 14C tissue radioactivity was removed during washing from the brain tissue slices of rats killed 30 min after 14C_ valine injection; 10% was removed from those killed 90 min after injection. This measured value for free valine in brain tissue agrees well with values calculated using valine rate constants (Kirikae et aI., 1988) and Eq. (3) representing theoretical amounts of free valine in the brain tissue (Smith et aI., 1984; Kirikae et aI., 1988) , again supporting ad equacy of the rate constants used.
DISCUSSION
Animal-to-animal variability can be a major ob stacle when assessing the relationship of different metabolic variables in a series of laboratory ani mals. A simple and reliable means to measure mul tiple physiological variables in a single animal is greatly desired. Multitracer autoradiographic tech niques are therefore extremely valuable. This is particularly the case with brain tumors, which are in many respects difficult to reproduce. It has been shown that tumor has a high rate of glucose utilization (Elliot et aI., 1935) . Using a dou ble-tracer autoradiographic method, we have eval uated the relationship between blood-flow and glu cose utilization, as well as the influence of the tu mor size on that relationship (Kato et aI., 1985b) . In a fast-growing tissue like tumor, one could also ex pect a high rate of protein synthesis.
The rate of amino acid incorporation into pro teins, often called the regional rate of protein syn thesis (rRPS), has been studied using various meth ods (Dwyer et aI., 1982; Blasberg et aI., 1980; Hoss mann et aI., 1983; Smith et aI., 1984; Bustany et aI., 1981) . From the rate of incorporation of a specific amino acid into proteins, we can obtain the rate of protein synthesis by measuring, by biochemical methods, the total amount of amino acid in the pro teins of a particular tissue. This conversion is not really essential, however, because the rate of incor poration is sufficient for comparing changes in duced by an external influence in different brain structures. When we compare the rates of amino acid incorporation and draw conclusions on the ba sis of the rates, we should keep in mind that differ ent amino acids are not equally abandoned in tissue proteins. This would be apparent in different rates of incorporation obtained for different amino acids but the rate of protein synthesis would be the same, regardless of what amino acid is used. studies of brain plasticity in the rat (1984) and mon key visual cortex (1987) . We, however, chose to use 1 4 C-valine, for two major reasons. The first is that the valine plasma concentration is high, about 200 nmol/ml (Azar et aI., 1973) , allowing easy measure ment of the plasma concentration. The second rea son is that brain levels of free leucine are lower than those of valine (Agrawal et aI., 1977; Lajtha and Toth 1974; Perry et aI., 1972 Perry et aI., , 1979 . The lower con centration of free leucine in the brain (Agrawal et aI., 1977; Lajtha and Toth 1974; Perry et aI., 1972 Perry et aI., , 1979 should theoretically be beneficial because the smaller brain concentration needs to be subtracted, reducing the influence of the rate constants on the final results. The rate of leucine incorporation is double that for valine, producing a larger amount of tracer taken up unidirectionally by tissue. Since leu cine is approximately twice as abundant in brain proteins (Agrawal et aI., 1977) as valine, the rate of leucine release from brain proteins is also twice that of valine. In light of these two facts, the assumption that no labeled amino acid is released into the brain amino acid pool used as a precursor to the rate limiting step might be violated in the leucine model.
Here we report on the rate of valine incorporation into implanted brain tumor and the influence of the tumor on the rate of incorporation into proteins in the contra-and ipsilateral cortices. We also exam ined the influence of the tumor on the relation be tween brain glucose and the rate of amino acid in corporation into proteins,
We measured the rate of valine incorporation by two different methods: kinetic [where the rates were calculated on the basis of the total tissue ra dioactivity at kill time and the rate constants mea sured in independent experiments in normal brain (Kirikae et aI., 1988)] , and "washing" [a TCA-washing method, analogous to the one described some time ago by Blasberg et al. (1980) and Dwyer et al. (1982) ]. The data in Table 3 show excellent agreement between the two methods and suggest that it is possible to measure the rate of valine in corporation into proteins after washing slices in TCA, removing tissue-free valine, and determining the amounts incorporated into proteins by autora diography.
Rats were killed at 30 and 90 min after the begin ning of 14C-valine injection. Since there was no dif ference in the rRPS in these two groups, the data were combined. Table 3 shows data obtained by two experimental approaches, kinetic and washing, for comparison. Since there was no significant dif ference between the rates estimated at different times by either method, we concluded that the rate constants are a good representation (at least for this purpose) of the "actual" kinetics of 1 4 C-valine in the rat brain. This agreement could result also from the insensitivity of this biological model (actually, a mathematical representation) to the absolute values of the rate constants (Sokoloff et aI., 1977; Kato et al., 1985a,b; Redies et al., 1987) .
The washed method is especially attractive be cause it removes the need to know the model rate constants, simplifying the application of the method to the study of pathology. The measurement of the rate constants in different pathologies might be time-consuming. The washed method would also eliminate any errors introduced in calculating the tissue-free valine as well as correcting for the delay of the equilibration of the precursor pool with the plasma [called the lag time by Sokoloff et aI., (1977) ]. Of course, one could prolong the experi ment, reducing the influence of the assumed rate constants on the final calculation, but this would increase the danger of having the same radioac tively labeled tracer released from proteins into the brain's free valine pool (recycling of the label).
We also confirmed the validity of the rate con stants by determining the acid-soluble fraction in the gray matter homogenates and comparing it with that estimated by the kinetic model. At 30 min, there was about 34% of total tissue radioactivity present as free valine, while at 90 min there was only about 10%. The agreement between the free valine as measured and as calculated by Eq. (5) was excellent.
The half-life of the precursor pool (as defined in the theoretical section of this paper) is short (Kiri kae et al., 1988) compared to the duration of exper iments, permitting the assumption that the inte grated specific activity of the precursor pool and that of the plasma are similar, if not exactly the same. It should be pointed out that the real precur sor of the incorporation of amino acid into proteins is aminoacyl-tRNA. As far as the biological model is concerned, it does not matter what the real pre cursor of proteins is. The only important thing is that there is a rate-limiting step beyond the BBB. It also does not matter which step is the rate-limiting one as long as the measurement is done after a time long enough to permit equilibration of plasma (sup ply compartment), and a compartment between plasma and the rate-limiting step. An analogy to this could be found in a chain radioactive decay where, after transient equilibrium is reached, the longest half-life governs decay of the chain (Friedlander et aI., 1964) . Only that half-life would be possible to measure (Friedlander et aI., 1964) . The longest half life in the chain decay is equivalent to the rate limiting step in biokinetics. Since tumor does not have a BBB, equilibration was reached even faster in the tumor than in normal brain.
In our experiments, the tracer was injected dur ing 1 min. We chose this injection schedule to re duce the risk of changing the plasma valine concen tration, thereby violating tracer kinetic principles, and to avoid any influence on the steady-state va line metabolism. The specific activity of 1 4 C-valine was 55 mCi/mmol or 0.45 J..L mollml of injected solu tion when expressed in J..L mollml. A total infusion of 7.5 nmol/s of valine was injected into the vein. By analyzing the rat plasma curve (Wagner, 1975) , one can estimate the half-life of the a component for removal of 1 4 C-valine from the plasma to be about 0.9 min. The blood sampling showed that the max imal radioactivity in the plasma 3 s after the end of injection is 600 nCi/ml. Using the above-mentioned specific activity of valine, this tranforms into an increase of 10.9 nmollml of valine. The injected amount is progressively diluted into the total blood pool. Assuming a blood flow in the rat heart of 2.5 ml/min (0.417 mIls), conversion into the circulation of valine gives a circulation of about 83 nmolls of valine through the heart. The addition of 7.5 nmol every second into the rat circulation would there fore not have any substantial effect on the steady state or plasma valine concentration. The measure ments of the plasma valine done before and 5 min after injection did not show any significant differ ence in the plasma valine concentration.
After this time (1 min injected), plasma radioac tivity is reduced with a half-life of 0.9 min. This would indicate that the maximal addition of valine to plasma is about 10.9 nmol/ml in the peak. This addition is about 5% of the total plasma valine con-centration. A small transient increase (5%) during a time less than 0.5 min should not have any serious effect on the steady state of valine metabolism.
Data reported in Table 2 indicate that the rate of valine incorporation in tumor is 22 times that in normal cortex. The rate of valine incorporation into proteins in the contralateral cortex (supposedly nor mal) is in reasonable agreement with the rates re ported by Smith et ai. (1984) for leucine, taking into account, of course, that leucine is about twice as abundant as valine in the brain proteins. Compari son with other data obtained by biochemical meth ods is also reasonable, especially when the use of different methodologies is considered. Glucose uti lization in the tumor is also substantially higher than that in the contralateral cortex. However, the tumor reduces glucose utilization in the ipsilateral cortex, probably because of either local pressure or disrup tion of the neuronal pathways. All of these results are in agreement with those reported by Kato et ai. (1985b) . High tumor glucose utilization and the rate of valine incorporation in the tumor tissue can be explained by high rates of cell proliferation requir ing high energy to sustain biochemical reactions and proteins as a structural matrix and for regeneration of different enzymes.
The ratio ot protein synthesis between the tumor and the contralateral parietal cortex is 15 times higher than the ratio of glucose utilization between the tumor and the contralateral parietal cortex. The protein synthesis in the normal brain tissue has a minimum influence from the secondary functional or local pressure factors. Thus, the protein synthe sis using L-[1_1 4 C]-valine promises to be a much more reliable and suitable metabolic parameter for assessing either the effectiveness of antitumor agents in the tumor or their neurotoxicity to normal brain tissue.
In conclusion, measurement of the rate of amino acid incorporation into tumor tissue will undoubt edly prove more reliable in identifying active brain tumor tissue than the use of glucose analogs (2-deoxyglucose of 2-fluoro-2-deoxyglucose). Recent studies using [llC-methyl]-S-labeled methionine and PET scanning in humans (Bergstrom et aI., 1983; Torizuka et aI., 1984; Syrota 1985; Schober et aI., 1987 ) support these findings.
NOTE ADDED IN PROOFS
Subsequent measurements of the plasma valine concentration in tumor-bearing rats in our other tu mor studies by a postcolumn derivatization re vealed that our precolumn derivatization had a sys-J Cereb Blood Flow Metab, Vol. 9, No. 1, 1989 temic error of about two. To correct for this, all values for the rate of valine incorporation should be multiplied by two in this paper as well as in Kirikae et ai. 's 1988 paper. 
